FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179828192> ?p ?o ?g. }

• W3179828192 abstract "Colorectal cancer (CRC) is the third leading cause of cancer-related deaths worldwide due to its poor prognosis. Most of the patients receive surgical resection when diagnosed as CRC, whereas the recurrence rate is very high. Therefore, additional treatment options, such as targeted therapy, are still urgently needed. The novel BH3 mimetic, APG1244 (a prodrug for APG1252), is a highly potent Bcl-2 and Bcl-XL dual inhibitor and being tested in clinical trials as a potential cancer therapeutic agent. The current study focuses on demonstrating the therapeutic efficacies of APG1244 against colorectal cancer and understanding the underlying mechanisms. A panel of CRC cell lines with different levels of Bcl-2, Bcl-XL and Mcl-1 possessed different sensitivities to APG1244. APG1244 effectively decreased the survival of CRC cell lines, particularly those expressing relative low levels of Mcl-1, with induction of apoptosis. High levels of Mcl-1 in these cell lines were significantly correlated to decreased sensitivity to APG1244. APG1244, when combined with a Mcl-1 inhibitor, synergistically decreased the survival and induced apoptosis of APG1244-insensitive cell lines with high levels of Mcl-1. This combination could further decreased the survival and enhanced apoptosis even in the cell lines with relatively low levels of Mcl-1, whereas enforced expression of ectopic Mcl-1 in these cells abrogated APG1244's effects on decreasing cell survival and inducing apoptosis, which can be reversed by Mcl-1 inhibition. In our study, it appears that APG1244 quickly activated caspase-8 and caspase-3 and induced PARP cleavage with induction of cytochrome C and Smac release from mitochondria. Deficiency of Bax, Smac, Bim or PUMA, but not FADD, in CRC cells protected (BAX-KO) or partially protected cells from APG1244-induced apoptosis, indicating that APG1244 induces Bax-dependent apoptosis. Furthermore, blockage of caspase-8 with a caspase-8 specific inhibitor abolished cleavage of caspase-3 and PARP including attenuation of cytochrome C and Smac release induced by APG1244, suggesting a caspase-8-dependent mechanism. The current study thus demonstrates the potential of APG1244 as a monotherapy in the treatment of CRC, particularly those with low Mcl-1 expression, or in combination with a Mcl-1 inhibitor for CRC treatment, warranting further evaluation in vivo and in the clinic.Citation Format: Weilong Yao, Shi-Yong Sun. Mcl-1 levels critically determines the sensitivities of human colon cancer cells to APG1244, a novel Bcl-2 and Bcl-XLinhibitor, that induces Bax- and caspase-8- dependent apoptosis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 977." @default.
• W3179828192 created "2021-07-19" @default.
• W3179828192 creator A5022570940 @default.
• W3179828192 creator A5088750854 @default.
• W3179828192 date "2021-07-01" @default.
• W3179828192 modified "2023-10-18" @default.
• W3179828192 title "Abstract 977: Mcl-1 levels critically determines the sensitivities of human colon cancer cells to APG1244, a novel Bcl-2 and Bcl-XLinhibitor, that induces Bax- and caspase-8- dependent apoptosis" @default.
• W3179828192 doi "https://doi.org/10.1158/1538-7445.am2021-977" @default.
• W3179828192 hasPublicationYear "2021" @default.
• W3179828192 type Work @default.
• W3179828192 sameAs 3179828192 @default.
• W3179828192 citedByCount "0" @default.
• W3179828192 crossrefType "proceedings-article" @default.
• W3179828192 hasAuthorship W3179828192A5022570940 @default.
• W3179828192 hasAuthorship W3179828192A5088750854 @default.
• W3179828192 hasConcept C121608353 @default.
• W3179828192 hasConcept C126322002 @default.
• W3179828192 hasConcept C143998085 @default.
• W3179828192 hasConcept C190283241 @default.
• W3179828192 hasConcept C31573885 @default.
• W3179828192 hasConcept C502942594 @default.
• W3179828192 hasConcept C526805850 @default.
• W3179828192 hasConcept C54355233 @default.
• W3179828192 hasConcept C55493867 @default.
• W3179828192 hasConcept C71924100 @default.
• W3179828192 hasConcept C81885089 @default.
• W3179828192 hasConcept C86803240 @default.
• W3179828192 hasConcept C98424977 @default.
• W3179828192 hasConceptScore W3179828192C121608353 @default.
• W3179828192 hasConceptScore W3179828192C126322002 @default.
• W3179828192 hasConceptScore W3179828192C143998085 @default.
• W3179828192 hasConceptScore W3179828192C190283241 @default.
• W3179828192 hasConceptScore W3179828192C31573885 @default.
• W3179828192 hasConceptScore W3179828192C502942594 @default.
• W3179828192 hasConceptScore W3179828192C526805850 @default.
• W3179828192 hasConceptScore W3179828192C54355233 @default.
• W3179828192 hasConceptScore W3179828192C55493867 @default.
• W3179828192 hasConceptScore W3179828192C71924100 @default.
• W3179828192 hasConceptScore W3179828192C81885089 @default.
• W3179828192 hasConceptScore W3179828192C86803240 @default.
• W3179828192 hasConceptScore W3179828192C98424977 @default.
• W3179828192 hasLocation W31798281921 @default.
• W3179828192 hasOpenAccess W3179828192 @default.
• W3179828192 hasPrimaryLocation W31798281921 @default.
• W3179828192 hasRelatedWork W1670069535 @default.
• W3179828192 hasRelatedWork W187494606 @default.
• W3179828192 hasRelatedWork W1966994924 @default.
• W3179828192 hasRelatedWork W2013258134 @default.
• W3179828192 hasRelatedWork W2022458862 @default.
• W3179828192 hasRelatedWork W2053279347 @default.
• W3179828192 hasRelatedWork W2071430908 @default.
• W3179828192 hasRelatedWork W2094933738 @default.
• W3179828192 hasRelatedWork W413994578 @default.
• W3179828192 hasRelatedWork W4200430624 @default.
• W3179828192 isParatext "false" @default.
• W3179828192 isRetracted "false" @default.
• W3179828192 magId "3179828192" @default.
• W3179828192 workType "article" @default.